1. Home
  2. AMBA vs KNSA Comparison

AMBA vs KNSA Comparison

Compare AMBA & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$70.29

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$42.76

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
KNSA
Founded
2004
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.4B
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
AMBA
KNSA
Price
$70.29
$42.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
7
Target Price
$97.25
$53.71
AVG Volume (30 Days)
600.9K
472.8K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
33.18
225.00
EPS
N/A
0.75
Revenue
$295,402,000.00
$677,564,000.00
Revenue This Year
$39.65
$62.99
Revenue Next Year
$9.86
$33.30
P/E Ratio
N/A
$76.32
Revenue Growth
N/A
60.09
52 Week Low
$38.90
$18.26
52 Week High
$96.69
$49.12

Technical Indicators

Market Signals
Indicator
AMBA
KNSA
Relative Strength Index (RSI) 56.06 44.36
Support Level $69.37 $41.98
Resistance Level $70.65 $42.91
Average True Range (ATR) 2.88 1.99
MACD 0.92 -0.21
Stochastic Oscillator 77.70 21.00

Price Performance

Historical Comparison
AMBA
KNSA

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: